Active Stock Evaluation – Synthetic Biologics, Inc. (NYSE:SYN)
Synthetic Biologics, Inc. (NYSE:SYN) has grabbed attention from the analysts, when it saw a value decrease of 1.75% in the
Read moreSynthetic Biologics, Inc. (NYSE:SYN) has grabbed attention from the analysts, when it saw a value decrease of 1.75% in the
Read moreShares of Synthetic Biologics, Inc. (NYSE:SYN) inclined 1.15% in morning trade Wednesday. The stock closed the last trade at $0.5899,
Read more